Bausch & Lomb Corp (BLCO) · Insider trading
What Bausch & Lomb's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$1.22M
9 insiders, 9 trades
Sold, 12 months
$1.19M
2 insiders, 0% under a plan
Net, 12 months
+$29,803
bought less sold
Latest filing
2026-08-14
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Munsch FrederickSVP, Controller and CAO | – | $887,662 | 1 | 2026-08-10 | 45,831 |
| Saunders Brent LDirector, CEO and Chairman of the Board | $500,118 | – | 2 | 2026-03-06 | 966,575 |
| Von Eschenbach Andrew C.Director | $99,838 | $306,708 | 4 | 2026-08-07 | 63,733 |
| Collis Steven HDirector | $267,150 | – | 1 | 2026-02-23 | 20,255 |
| Bailey A Robert DEVP & Chief Legal Officer | $250,390 | – | 1 | 2026-03-06 | 231,890 |
| Ross Thomas W. Sr.Director | $79,560 | – | 1 | 2026-03-03 | 64,891 |
| Robertson Russel CDirector | $78,760 | – | 1 | 2026-02-20 | 72,407 |
| Alfonso EduardoDirector | $76,970 | – | 1 | 2026-03-02 | 9,555 |
| Ling KarenDirector | $70,960 | – | 1 | 2026-02-19 | 41,676 |
| Eldessouky SamEVP and CFO | $68,520 | – | 1 | 2026-03-06 | 403,130 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Munsch FrederickSVP, Controller and CAO | Sale | 52,900 | 16.78 | $887,662 | 45,831 | Form 4 |
| 2026-08-07 | Von Eschenbach Andrew C.Director | Sale | 6,059 | 16.58 | $100,458 | 63,733 | Form 4 |
| 2026-08-06 | Von Eschenbach Andrew C.Director | Sale | 12,500 | 16.50 | $206,250 | 69,792 | Form 4 |
| 2026-03-06 | Saunders Brent LDirector, CEO and Chairman of the Board | Buy | 14,700 | 17.14 | $251,958 | 966,575 | Form 4 |
| 2026-03-06 | Eldessouky SamEVP and CFO | Buy | 4,000 | 17.13 | $68,520 | 403,130 | Form 4 |
| 2026-03-06 | Bailey A Robert DEVP & Chief Legal Officer | Buy | 14,600 | 17.15 | $250,390 | 231,890 | Form 4 |
| 2026-03-03 | Ross Thomas W. Sr.Director | Buy | 4,500 | 17.68 | $79,560 | 64,891 | Form 4 |
| 2026-03-02 | Alfonso EduardoDirector | Buy | 4,300 | 17.90 | $76,970 | 9,555 | Form 4 |
| 2026-02-27 | Von Eschenbach Andrew C.Director | Buy | 4,364 | 18.31 | $79,905 | 66,450 | Form 4 |
| 2026-02-23 | Collis Steven HDirector | Buy | 15,000 | 17.81 | $267,150 | 20,255 | Form 4 |
| 2026-02-20 | Robertson Russel CDirector | Buy | 4,400 | 17.90 | $78,760 | 72,407 | Form 4 |
| 2026-02-19 | Ling KarenDirector | Buy | 4,000 | 17.74 | $70,960 | 41,676 | Form 4 |
| 2025-05-22 | Saunders Brent LDirector, CEO and Chairman of the Board | Buy | 22,000 | 11.28 | $248,160 | 719,156 | Form 4 |
| 2025-05-02 | Von Eschenbach Andrew C.Director | Buy | 1,695 | 11.76 | $19,933 | 41,748 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
72 × grant or award48 × shares withheld for tax
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Chersi Robert JDirector | Grant or award A | +11,776 | – | 11,776 | Form 4 |
| 2026-08-12 | Paul Laurence eDirector | Grant or award A | +11,776 | – | 11,776 | Form 4 |
| 2026-08-12 | Trebbi BarbaraDirector | Grant or award A | +11,776 | – | 11,776 | Form 4 |
| 2026-08-05 | Saunders Brent LDirector, Chairman of the Board and CEO | Shares withheld for tax F | −4,231 | 16.76 | 974,158 | Form 4 |
| 2026-08-05 | Saunders Brent LDirector, Chairman of the Board and CEO | Grant or award A | +281,879 | – | 1,256,037 | Form 4 |
| 2026-08-05 | Bailey A Robert DEVP & Chief Legal Officer | Grant or award A | +33,557 | – | 264,241 | Form 4 |
| 2026-08-05 | Bonnefoy LucPresident, Surgical | Grant or award A | +16,778 | – | 103,801 | Form 4 |
| 2026-08-05 | Eldessouky SamEVP and CFO | Grant or award A | +50,335 | – | 393,527 | Form 4 |
| 2026-08-05 | Hashad YehiaEVP of R&D and CMO | Grant or award A | +20,973 | – | 187,350 | Form 4 |
| 2026-08-05 | Munsch FrederickSVP, Controller and CAO | Grant or award A | +9,091 | – | 98,731 | Form 4 |
| 2026-08-05 | Stewart Andrew J.President, GPIC | Grant or award A | +16,778 | – | 103,211 | Form 4 |
| 2026-06-12 | Bonnefoy LucPresident, Surgical | Shares withheld for tax F | −1,008 | 15.08 | 87,023 | Form 4 |
| 2026-05-26 | Alfonso EduardoDirector | Grant or award A | +15,842 | 15.78 | 31,072 | Form 4 |
| 2026-05-26 | Bernier Nathalie D.Director | Grant or award A | +15,842 | 15.78 | 85,505 | Form 4 |
| 2026-05-26 | Collis Steven HDirector | Grant or award A | +15,842 | 15.78 | 42,003 | Form 4 |
| 2026-05-26 | Kavanagh Sarah BDirector | Grant or award A | +15,842 | 15.78 | 69,541 | Form 4 |
| 2026-05-26 | Ling KarenDirector | Grant or award A | +15,842 | 15.78 | 61,518 | Form 4 |
| 2026-05-26 | Paulson JohnDirector | Grant or award A | +15,842 | 15.78 | 89,823 | Form 4 |
| 2026-05-26 | Robertson Russel CDirector | Grant or award A | +15,842 | 15.78 | 94,260 | Form 4 |
| 2026-05-26 | Ross Thomas W. Sr.Director | Grant or award A | +15,842 | 15.78 | 85,233 | Form 4 |
| 2026-05-26 | Von Eschenbach Andrew C.Director | Grant or award A | +15,842 | 15.78 | 86,656 | Form 4 |
| 2026-05-22 | Saunders Brent LDirector, Chairman of the Board and CEO | Shares withheld for tax F | −2,886 | 15.92 | 978,389 | Form 4 |
| 2026-05-05 | Bonnefoy LucPresident, Surgical | Shares withheld for tax F | −11,970 | 16.00 | 88,031 | Form 4 |
| 2026-05-05 | Munsch FrederickSVP, Controller and CAO | Shares withheld for tax F | −8,673 | 16.00 | 89,640 | Form 4 |
| 2026-05-05 | Hashad YehiaEVP of R&D and CMO | Shares withheld for tax F | −13,664 | 16.00 | 166,377 | Form 4 |
| 2026-05-05 | Eldessouky SamEVP and CFO | Shares withheld for tax F | −63,938 | 16.00 | 343,192 | Form 4 |
| 2026-04-30 | Alfonso EduardoDirector | Grant or award A | +1,375 | 15.90 | 15,230 | Form 4 |
| 2026-04-30 | Collis Steven HDirector | Grant or award A | +1,415 | 15.90 | 26,161 | Form 4 |
| 2026-04-30 | Paulson JohnDirector | Grant or award A | +1,375 | 15.90 | 73,981 | Form 4 |
| 2026-04-30 | Robertson Russel CDirector | Grant or award A | +1,611 | 15.90 | 78,418 | Form 4 |
| 2026-04-24 | Bailey A Robert DEVP & Chief Legal Officer | Shares withheld for tax F | −15,806 | 15.82 | 230,684 | Form 4 |
| 2026-04-24 | Stewart Andrew J.President, GPIC | Shares withheld for tax F | −4,216 | 15.82 | 86,433 | Form 4 |
| 2026-03-06 | Saunders Brent LDirector, CEO and Chairman of the Board | Grant or award A | +14,700 | – | 981,275 | Form 4 |
| 2026-03-06 | Eldessouky SamEVP and CFO | Grant or award A | +4,000 | – | 407,130 | Form 4 |
| 2026-03-06 | Bailey A Robert DEVP & Chief Legal Officer | Grant or award A | +14,600 | – | 246,490 | Form 4 |
| 2026-03-03 | Ross Thomas W. Sr.Director | Grant or award A | +4,500 | – | 69,391 | Form 4 |
| 2026-03-02 | Alfonso EduardoDirector | Grant or award A | +4,300 | – | 13,855 | Form 4 |
| 2026-02-27 | Von Eschenbach Andrew C.Director | Grant or award A | +4,364 | – | 70,814 | Form 4 |
| 2026-02-27 | Saunders Brent LDirector, CEO and Chairman of the Board | Shares withheld for tax F | −24,649 | 18.30 | 951,875 | Form 4 |
| 2026-02-27 | Eldessouky SamEVP and CFO | Shares withheld for tax F | −15,507 | 18.30 | 450,600 | Form 4 |
| 2026-02-27 | Eldessouky SamEVP and CFO | Shares withheld for tax F | −51,470 | 18.30 | 399,130 | Form 4 |
| 2026-02-27 | Bailey A Robert DEVP & Chief Legal Officer | Shares withheld for tax F | −2,461 | 18.30 | 217,290 | Form 4 |
| 2026-02-27 | Hashad YehiaEVP of R&D and CMO | Shares withheld for tax F | −5,075 | 18.30 | 191,662 | Form 4 |
| 2026-02-27 | Hashad YehiaEVP of R&D and CMO | Shares withheld for tax F | −11,621 | 18.30 | 180,041 | Form 4 |
| 2026-02-27 | Bonnefoy LucPresident, Surgical | Shares withheld for tax F | −4,311 | 18.30 | 109,222 | Form 4 |
| 2026-02-27 | Bonnefoy LucPresident, Surgical | Shares withheld for tax F | −9,221 | 18.30 | 100,001 | Form 4 |
| 2026-02-27 | Stewart Andrew J.President, GPIC | Shares withheld for tax F | −2,007 | 18.30 | 90,649 | Form 4 |
| 2026-02-27 | Munsch FrederickSVP, Controller and CAO | Shares withheld for tax F | −2,437 | 18.30 | 104,005 | Form 4 |
| 2026-02-27 | Munsch FrederickSVP, Controller and CAO | Shares withheld for tax F | −5,692 | 18.30 | 98,313 | Form 4 |
| 2026-02-26 | Saunders Brent LDirector, CEO and Chairman of the Board | Shares withheld for tax F | −22,059 | 18.49 | 976,524 | Form 4 |
| 2026-02-26 | Eldessouky SamEVP and CFO | Shares withheld for tax F | −7,062 | 18.49 | 466,107 | Form 4 |
| 2026-02-26 | Bailey A Robert DEVP & Chief Legal Officer | Shares withheld for tax F | −3,395 | 18.49 | 219,751 | Form 4 |
| 2026-02-26 | Hashad YehiaEVP of R&D and CMO | Shares withheld for tax F | −2,169 | 18.49 | 196,737 | Form 4 |
| 2026-02-26 | Bonnefoy LucPresident, Surgical | Shares withheld for tax F | −4,404 | 18.49 | 113,533 | Form 4 |
| 2026-02-26 | Stewart Andrew J.President, GPIC | Shares withheld for tax F | −2,984 | 18.49 | 92,656 | Form 4 |
| 2026-02-26 | Munsch FrederickSVP, Controller and CAO | Shares withheld for tax F | −2,042 | 18.49 | 106,442 | Form 4 |
| 2026-02-25 | Saunders Brent LDirector, CEO and Chairman of the Board | Grant or award A | +327,102 | – | 998,583 | Form 4 |
| 2026-02-25 | Eldessouky SamEVP and CFO | Grant or award A | +81,775 | – | 473,169 | Form 4 |
| 2026-02-25 | Bailey A Robert DEVP & Chief Legal Officer | Grant or award A | +52,570 | – | 223,146 | Form 4 |
| 2026-02-25 | Hashad YehiaEVP of R&D and CMO | Grant or award A | +35,046 | – | 198,906 | Form 4 |
| 2026-02-25 | Stewart Andrew J.President, GPIC | Grant or award A | +32,710 | – | 95,640 | Form 4 |
| 2026-02-25 | Bonnefoy LucPresident, Surgical | Grant or award A | +30,373 | – | 117,937 | Form 4 |
| 2026-02-25 | Munsch FrederickSVP, Controller and CAO | Grant or award A | +18,253 | – | 108,484 | Form 4 |
| 2026-02-23 | Saunders Brent LDirector, CEO and Chairman of the Board | Shares withheld for tax F | −65,444 | 17.99 | 671,481 | Form 4 |
| 2026-02-23 | Collis Steven HDirector | Grant or award A | +4,491 | – | 24,746 | Form 4 |
| 2026-02-20 | Robertson Russel CDirector | Grant or award A | +4,400 | – | 76,807 | Form 4 |
| 2026-02-19 | Paulson JohnDirector | Grant or award A | +1,239 | 17.65 | 72,606 | Form 4 |
| 2026-02-19 | Robertson Russel CDirector | Grant or award A | +1,451 | 17.65 | 68,007 | Form 4 |
| 2026-02-19 | Alfonso EduardoDirector | Grant or award A | +5,255 | – | 5,255 | Form 4 |
| 2026-02-19 | Collis Steven HDirector | Grant or award A | +5,255 | – | 5,255 | Form 4 |
| 2026-02-19 | Ling KarenDirector | Grant or award A | +4,000 | – | 45,676 | Form 4 |
| 2026-02-18 | Eldessouky SamEVP and CFO | Grant or award A | +70,578 | – | 391,394 | Form 4 |
| 2026-02-18 | Hashad YehiaEVP of R&D and CMO | Grant or award A | +29,406 | – | 163,860 | Form 4 |
| 2026-02-18 | Bonnefoy LucPresident, Surgical | Grant or award A | +10,202 | – | 87,564 | Form 4 |
| 2026-02-18 | Munsch FrederickSVP, Controller and CAO | Grant or award A | +12,498 | – | 90,231 | Form 4 |
| 2025-11-14 | Paulson JohnDirector | Grant or award A | +1,402 | 15.60 | 71,367 | Form 4 |
| 2025-11-14 | Robertson Russel CDirector | Grant or award A | +1,642 | 15.60 | 66,556 | Form 4 |
| 2025-08-05 | Saunders Brent LDirector, CEO and Chairman of the Board | Shares withheld for tax F | −4,231 | 14.44 | 736,925 | Form 4 |
| 2025-08-05 | Hashad YehiaEVP of R&D and CMO | Grant or award A | +17,715 | – | 134,454 | Form 4 |
| 2025-08-05 | Bonnefoy LucPresident, Surgical | Grant or award A | +6,146 | – | 77,362 | Form 4 |
| 2025-08-05 | Eldessouky SamEVP and CFO | Grant or award A | +42,517 | – | 320,816 | Form 4 |
| 2025-08-05 | Munsch FrederickSVP, Controller and CAO | Grant or award A | +7,529 | – | 77,733 | Form 4 |
| 2025-07-25 | Eldessouky SamEVP and CFO | Shares withheld for tax F | −3,996 | 14.32 | 278,299 | Form 4 |
| 2025-07-25 | Munsch FrederickSVP, Controller and CAO | Shares withheld for tax F | −1,090 | 14.32 | 70,204 | Form 4 |
| 2025-07-25 | Bonnefoy LucPresident, Surgical | Shares withheld for tax F | −2,167 | 14.32 | 71,216 | Form 4 |
| 2025-07-25 | Hashad YehiaEVP of R&D and CMO | Shares withheld for tax F | −2,841 | 14.32 | 116,739 | Form 4 |
| 2025-06-13 | Bonnefoy LucPresident, Surgical | Shares withheld for tax F | −968 | 12.33 | 73,383 | Form 4 |
| 2025-05-27 | Bernier Nathalie D.Director | Grant or award A | +20,338 | – | 69,663 | Form 4 |
| 2025-05-27 | Hu GaoxiangDirector | Grant or award A | +20,338 | – | 61,147 | Form 4 |
| 2025-05-27 | Icahn BrettDirector | Grant or award A | +20,338 | – | 61,147 | Form 4 |
| 2025-05-27 | Kavanagh Sarah BDirector | Grant or award A | +20,338 | – | 53,699 | Form 4 |
| 2025-05-27 | Ling KarenDirector | Grant or award A | +20,338 | – | 37,676 | Form 4 |
| 2025-05-27 | Paulson JohnDirector | Grant or award A | +20,338 | – | 69,965 | Form 4 |
| 2025-05-27 | Robertson Russel CDirector | Grant or award A | +20,338 | – | 64,914 | Form 4 |
| 2025-05-27 | Ross Thomas W. Sr.Director | Grant or award A | +20,338 | – | 60,391 | Form 4 |
| 2025-05-27 | Von Eschenbach Andrew C.Director | Grant or award A | +20,338 | – | 62,086 | Form 4 |
| 2025-05-22 | Saunders Brent LDirector, CEO and Chairman of the Board | Grant or award A | +22,000 | – | 741,156 | Form 4 |
| 2025-05-01 | Paulson JohnDirector | Grant or award A | +1,887 | 11.59 | 49,627 | Form 4 |
| 2025-05-01 | Robertson Russel CDirector | Grant or award A | +2,210 | 11.59 | 44,576 | Form 4 |
| 2025-04-24 | Bailey A Robert DEVP & Chief Legal Officer | Shares withheld for tax F | −9,781 | 13.89 | 170,576 | Form 4 |
| 2025-04-24 | Stewart Andrew J.See remarks | Shares withheld for tax F | −3,954 | 13.89 | 62,930 | Form 4 |
| 2025-02-28 | Bonnefoy LucPresident,Surgical | Shares withheld for tax F | −1,110 | 16.00 | 77,380 | Form 4 |
| 2025-02-28 | Bonnefoy LucPresident,Surgical | Shares withheld for tax F | −3,029 | 16.00 | 74,351 | Form 4 |
| 2025-02-26 | Saunders Brent LDirector, CEO and Chairman of the Board | Grant or award A | +168,168 | – | 697,156 | Form 4 |
| 2025-02-26 | Eldessouky SamEVP and CFO | Grant or award A | +59,459 | – | 282,295 | Form 4 |
| 2025-02-26 | Bailey A Robert DEVP & Chief Legal Officer | Grant or award A | +40,540 | – | 180,357 | Form 4 |
| 2025-02-26 | Hashad YehiaEVP of R&D and CMO | Grant or award A | +25,225 | – | 119,580 | Form 4 |
| 2025-02-26 | Stewart Andrew J.See remarks | Grant or award A | +23,423 | – | 66,884 | Form 4 |
| 2025-02-26 | Bonnefoy LucPresident,Surgical | Grant or award A | +23,423 | – | 78,490 | Form 4 |
| 2025-02-26 | Munsch FrederickSVP, Controller and CAO | Grant or award A | +18,581 | – | 71,294 | Form 4 |
| 2024-12-23 | Bailey A Robert DEVP & Chief Legal Officer | Shares withheld for tax F | −4,402 | 17.83 | 139,817 | Form 4 |
| 2024-12-23 | Eldessouky SamEVP and CFO | Shares withheld for tax F | −7,249 | 17.83 | 231,418 | Form 4 |
| 2024-12-23 | Eldessouky SamEVP and CFO | Shares withheld for tax F | −8,582 | 17.83 | 222,836 | Form 4 |
| 2024-12-23 | Hashad YehiaEVP of R&D and CMO | Shares withheld for tax F | −2,324 | 17.83 | 97,106 | Form 4 |
| 2024-12-23 | Hashad YehiaEVP of R&D and CMO | Shares withheld for tax F | −2,751 | 17.83 | 94,355 | Form 4 |
| 2024-12-23 | Munsch FrederickSVP, Controller and CAO | Shares withheld for tax F | −908 | 17.83 | 54,905 | Form 4 |
| 2024-12-23 | Munsch FrederickSVP, Controller and CAO | Shares withheld for tax F | −2,192 | 17.83 | 52,713 | Form 4 |
| 2024-12-23 | Saunders Brent LDirector, CEO and Chairman of the Board | Shares withheld for tax F | −73,782 | 17.83 | 553,637 | Form 4 |
| 2024-12-23 | Saunders Brent LDirector, CEO and Chairman of the Board | Shares withheld for tax F | −24,649 | 17.83 | 528,988 | Form 4 |
| 2024-12-23 | Stewart Andrew J.See remarks | Shares withheld for tax F | −2,524 | 17.83 | 43,461 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.